Since SIL23 is only moderately selective for α-syn fibrils over Aβ and tau fibrils, it is likely to have significant binding in AD, PSP and CBD tissue, and thus could be utilized in competitive binding assays to determine the selectivity of unlabeled ligands in tissue assays. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.